|
gptkbp:instanceOf
|
Controlled substance schedule
|
|
gptkbp:administeredBy
|
gptkb:Drug_Enforcement_Administration
|
|
gptkbp:contrastsWith
|
gptkb:Schedule_I
gptkb:Schedule_III
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:criteria
|
Abuse may lead to severe psychological or physical dependence
Currently accepted medical use in treatment in the United States
High potential for abuse
|
|
gptkbp:example
|
gptkb:Cocaine
gptkb:Adderall
gptkb:Amphetamine
gptkb:Dexmethylphenidate
gptkb:Hydrocodone
gptkb:Hydromorphone
gptkb:Meperidine
gptkb:Methylphenidate
gptkb:Morphine
gptkb:Oxycodone
gptkb:Pentobarbital
gptkb:Secobarbital
gptkb:Tapentadol
Methamphetamine
Fentanyl
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schedule II
|
|
gptkbp:legalStatus
|
Controlled
|
|
gptkbp:partOf
|
gptkb:Controlled_Substances_Act
|
|
gptkbp:prohibits
|
Refills without new prescription
|
|
gptkbp:regulates
|
Drugs with accepted medical use
Drugs with high potential for abuse
|
|
gptkbp:requires
|
Prescription
|
|
gptkbp:bfsParent
|
gptkb:Controlled_Substances_Act
|
|
gptkbp:bfsLayer
|
5
|